CASP2 and neoplasm: Here, we demonstrate that BID levels regulate an AURKB/CASP-2 mitotic checkpoint that determines the fate of tumor cells when the SAC is overridden; senescence if BID expression is low but cell death in case of high BID levels (Fig. 7A).